Electronic Study for Anastrozole Pharmacovigilance Evaluation

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

NCT00544986 ·Status: COMPLETED ·Phase: PHASE4

Secondary Adjuvant Long Term Study With Arimidex

NCT00295620 ·Status: COMPLETED ·Phase: PHASE3

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

NCT00562458 ·Status: COMPLETED

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

NCT00871858 ·Status: COMPLETED ·Phase: PHASE2

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

NCT00259090 ·Status: COMPLETED ·Phase: PHASE2

Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women

NCT01300351 ·Status: COMPLETED ·Phase: PHASE3

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

NCT00300508 ·Status: COMPLETED ·Phase: PHASE3

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

NCT01953588 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

Study of Breast Cancer Prevention by Letrozole in High Risk Women

NCT00579826 ·Status: COMPLETED ·Phase: PHASE2

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

NCT00543127 ·Status: TERMINATED ·Phase: PHASE3

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

NCT00629616 ·Status: COMPLETED ·Phase: PHASE2

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

NCT00530868 ·Status: COMPLETED ·Phase: PHASE2

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

NCT01077453 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

NCT02007512 ·Status: COMPLETED ·Phase: PHASE2

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

NCT00005886 ·Status: COMPLETED ·Phase: PHASE1

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

NCT00248170 ·Status: COMPLETED ·Phase: PHASE3

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

NCT00638391 ·Status: COMPLETED

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

NCT00238316 ·Status: COMPLETED ·Phase: PHASE2

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

NCT01602380 ·Status: COMPLETED ·Phase: PHASE3

Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

NCT00542594 ·Status: TERMINATED

Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

NCT00332852 ·Status: COMPLETED ·Phase: PHASE3

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

NCT00921115 ·Status: COMPLETED ·Phase: PHASE2

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

NCT01151215 ·Status: TERMINATED ·Phase: PHASE2